Glenview Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$1.01B |
| 2 |
Labcorp
LH
|
+$483M |
| 3 |
ManpowerGroup
MAN
|
+$325M |
| 4 |
Booking.com
BKNG
|
+$318M |
| 5 |
Thermo Fisher Scientific
TMO
|
+$306M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$490M |
| 2 |
eBay
EBAY
|
+$257M |
| 3 |
American International
AIG
|
+$254M |
| 4 |
Danaher
DHR
|
+$149M |
| 5 |
Mohawk Industries
MHK
|
+$146M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 40.7% |
| 2 | Consumer Discretionary | 11.23% |
| 3 | Technology | 9.51% |
| 4 | Industrials | 8.66% |
| 5 | Materials | 7.81% |
Similar funds
Glenview Capital Management's Q2 2015 Portfolio in Review
As of Q2 2015, Glenview Capital Management held 89 positions worth $25.3B, up 15% from $21.9B the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Glenview Capital Management deployed $3.04B of net new capital in Q2 2015, opening 10 new positions and adding to 31 existing holdings. Its largest new stake was Labcorp: 4,636,905 shares worth $483M.
By sector, the portfolio is most concentrated in Healthcare at 41% of assets, up from 33% a quarter earlier, followed by Consumer Discretionary and Technology.
On the sell side, the largest reduction was eBay, an estimated $257M trimmed.
- Glenview Capital Management's largest Q2 2015 buy was Labcorp: 4,636,905 shares worth $483M.
- Glenview Capital Management added most to AbbVie in Q2 2015, an estimated $1.01B increase.
- Glenview Capital Management's biggest Q2 2015 reduction was eBay, cutting an estimated $257M.
- Glenview Capital Management fully exited TIME WARNER CABLE INC NEW COM STK in Q2 2015, selling an estimated $490M.
- Glenview Capital Management's ten largest holdings make up 38% of its $25.3B portfolio in Q2 2015.
- Glenview Capital Management opened 10 new positions and closed 8 in Q2 2015.
- Glenview Capital Management's portfolio value rose 15% quarter-over-quarter to $25.3B.
Based on Glenview Capital Management's 13F filing for Q2 2015, filed 14 Aug 2015.